Needham Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating
Express News | Needham Reiterates Hold on Vertex Pharmaceuticals
Express News | Vertex Pharmaceuticals Inc : Bernstein Raises Target Price to $502 From $458
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic
Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact
Actinium Wins FDA Nod to Conduct Clinical Trial for Radiotherapy
Is Vertex Pharmaceuticals' Monopoly in Danger?
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts
Vertex Pharmaceuticals(VRTX.US) Officer Sells US$7.56 Million in Common Stock
Albemarle Is Out of Wells Fargo's Signature Picks
Here Is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock
Vertex Pharmaceuticals Is Maintained at Buy by TD Cowen
What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
Express News | Vertex Pharmaceuticals Inc : TD Cowen Raises Target Price to $500 From $450
Piper Sandler Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $500
TD Cowen Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $500
TD Cowen Adjusts Price Target on Vertex Pharmaceuticals to $500 From $450, Maintains Buy Rating
No Data